Teleflex (NYSE:TFX) Posts Quarterly Earnings Results

Teleflex (NYSE:TFX) released its earnings results on Thursday. The medical technology company reported $3.89 earnings per share for the quarter, topping the consensus estimate of $3.86 by $0.03, Zacks reports. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Stock Down 20.7 %

Shares of TFX traded down $36.76 during midday trading on Thursday, reaching $140.87. 1,929,834 shares of the stock were exchanged, compared to its average volume of 573,671. The company has a market cap of $6.54 billion, a price-to-earnings ratio of 27.98, a P/E/G ratio of 1.73 and a beta of 1.16. The firm has a 50 day simple moving average of $177.07 and a 200-day simple moving average of $206.17. Teleflex has a 12-month low of $135.95 and a 12-month high of $249.90. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, March 7th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.97%. Teleflex’s payout ratio is currently 27.04%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial dropped their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $246.00.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.